[go: up one dir, main page]

MX2018002075A - Composicion que comprende taninos. - Google Patents

Composicion que comprende taninos.

Info

Publication number
MX2018002075A
MX2018002075A MX2018002075A MX2018002075A MX2018002075A MX 2018002075 A MX2018002075 A MX 2018002075A MX 2018002075 A MX2018002075 A MX 2018002075A MX 2018002075 A MX2018002075 A MX 2018002075A MX 2018002075 A MX2018002075 A MX 2018002075A
Authority
MX
Mexico
Prior art keywords
composition
tannins
mucous membranes
adhere
enhancing
Prior art date
Application number
MX2018002075A
Other languages
English (en)
Inventor
Giovagnoni Emiliano
Burini Michele
Marini Francesca
Original Assignee
Aboca Spa Societa Agricola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aboca Spa Societa Agricola filed Critical Aboca Spa Societa Agricola
Publication of MX2018002075A publication Critical patent/MX2018002075A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una nueva composición capaz de potenciar la capacidad de los taninos para adherirse a membranas mucosas (mucosas) y piel, su uso como composición terapéutica y productos que consisten en o que comprenden dicha composición.
MX2018002075A 2015-08-20 2016-08-19 Composicion que comprende taninos. MX2018002075A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A003171A ITUB20153171A1 (it) 2015-08-20 2015-08-20 Composizione comprendente tannini
PCT/IB2016/054975 WO2017029643A1 (en) 2015-08-20 2016-08-19 Composition comprising tannins

Publications (1)

Publication Number Publication Date
MX2018002075A true MX2018002075A (es) 2018-06-18

Family

ID=54884149

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018002075A MX2018002075A (es) 2015-08-20 2016-08-19 Composicion que comprende taninos.

Country Status (10)

Country Link
US (1) US11357813B2 (es)
EP (1) EP3337566B1 (es)
CN (1) CN108136210B (es)
AU (1) AU2016307998B2 (es)
BR (1) BR112018002257A2 (es)
CA (1) CA2993767A1 (es)
EA (1) EA039055B1 (es)
IT (1) ITUB20153171A1 (es)
MX (1) MX2018002075A (es)
WO (1) WO2017029643A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108567644B (zh) * 2018-07-17 2021-01-12 浙江伊瑟奇医药科技有限公司 一种长效保湿防晒化妆品及制备方法
IT201800010393A1 (it) * 2018-11-19 2019-02-19 Biohealth Italia Srl Integratore alimentare atto a ridurre il rilascio di agenti infiammatori e relativo uso
FR3095760B1 (fr) * 2019-05-07 2022-05-13 Fabre Pierre Dermo Cosmetique Extrait d’aigremoine comme agent anti-pollution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2608800A (en) * 1999-01-12 2000-08-01 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
US20040013710A1 (en) * 2001-07-20 2004-01-22 Howell Amy B. Hydrolyzable tannin extracts from plants effective at inhibiting bacterial adherence to surfaces
ITRM20030204A1 (it) * 2003-04-29 2004-10-30 Provincia Italiana Della Congregazi One Dei Figli Formulazione dermatologica.
CN1295247C (zh) * 2004-04-14 2007-01-17 福州绿谷生物药业技术研究所 灵芝多糖蛋白及其制备方法与用途
DE102004062775A1 (de) * 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
US20100062087A1 (en) * 2006-06-02 2010-03-11 Interhealth Nutraceuticals, Inc. Nutraceutical Treatments for Diabetic and Non-Diabetic Wound Healing
IT1391658B1 (it) * 2008-11-10 2012-01-17 Aboca Spa Societa Agricola Estratti di piante medicinali ottenibili per rimozione o neutralizzazione della frazione farmacologicamente attiva e composizioni che li contengono
US8338361B2 (en) * 2009-01-13 2012-12-25 Kao Corporation Fragrance composition
CN102370695B (zh) * 2010-08-19 2014-04-16 黑龙江省中医研究院 一种青龙衣活性提取物及其制备方法和用途
CN101940642B (zh) * 2010-10-08 2013-05-22 华东理工大学 一种中药组合物及其应用
GB201019297D0 (en) * 2010-11-15 2010-12-29 Pitt Elaine Improved compositions
WO2013149323A1 (en) * 2012-04-02 2013-10-10 Ntegrity Natural products for skin care
ITRM20120453A1 (it) * 2012-09-21 2014-03-22 Aboca Spa Societa Agricola Nuovi estratti di incenso e loro usi.
ITRM20130716A1 (it) * 2013-12-23 2015-06-24 Aboca Spa Societa Agricola Composizione per uso nel trattamento della tosse persistente

Also Published As

Publication number Publication date
CA2993767A1 (en) 2017-02-23
US11357813B2 (en) 2022-06-14
CN108136210B (zh) 2020-12-11
WO2017029643A1 (en) 2017-02-23
ITUB20153171A1 (it) 2017-02-20
US20190125817A1 (en) 2019-05-02
AU2016307998B2 (en) 2019-02-21
AU2016307998A1 (en) 2018-02-15
BR112018002257A2 (en) 2018-09-18
EA201890209A1 (ru) 2018-07-31
CN108136210A (zh) 2018-06-08
EP3337566A1 (en) 2018-06-27
EA039055B1 (ru) 2021-11-26
EP3337566B1 (en) 2020-12-23

Similar Documents

Publication Publication Date Title
CO2017011535A2 (es) Composiciones de ácido obeticólico y métodos de uso
MX2016009625A (es) Proteinas quimericas tipo fosfatasa alcalina.
SV2018005610A (es) Derivados de oxopiridina sustituidos
CO2017011851A2 (es) Compuestos novedosos
MX2018014154A (es) Polinucleotidos moduladores.
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
MX383164B (es) Composicion que contiene arn para tratamiento de enfermedades tumorales.
MX367521B (es) Composiciones de insulina de rápida acción.
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
BR112017000456A2 (pt) composições antivirais tópicas e métodos de uso das mesmas
CL2015000608A1 (es) Formulaciones de daptomicina y usos de la misma
MX2017006953A (es) Medicamentos para disminuir la evolucion de la enfermedad de parkinson.
CO7250444A2 (es) Uso de seaprose para eliminar biopelículas bacterianas
DOP2017000064A (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
UY35747A (es) Derivados sustituidos de fenilalanina
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CR20160529A (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
NI201500175A (es) Compuestos nuevos para el tratamiento del cáncer
DOP2018000049A (es) Compuestos para uso en aplicaciones antibacterianas
UY36292A (es) Compuestos de tetrahidroquinolina para su uso como inhibidores de bromodominios
GT201600252A (es) Derivados de naftiridinadiona
UY35745A (es) Derivados sustituidos de fenilalanina
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
PE20160596A1 (es) Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana